Soohyun Jessica Chon, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 131 Patrick Ave, Willow Springs, IL 60480 Phone: 312-301-7433 |
Daniel Y. Tam, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8502 Bucki Ln, Willow Springs, IL 60480 Phone: 708-408-9833 Fax: 708-386-9421 |
Dr. Nicole Marie Kostelc, PHARMD Pharmacist - Geriatric Medicare: Not Enrolled in Medicare Practice Location: 8400 Willow West Dr, Willow Springs, IL 60480 Phone: 708-839-8990 |
News Archive
Drug discovery and development company Esperance Pharmaceuticals today announced that it has begun enrollment and dosing of patients in a Phase 1 study of EP-100 in patients with advanced solid tumors. EP-100, the lead candidate from Esperance's Cationic Lytic Peptide (CLYP(TM)) platform technology, is a targeted membrane-disrupting peptide (tMDP) designed to seek and destroy cancer cells that over-express luteinizing hormone releasing hormone (LHRH) receptors on their surfaces.
Many barriers prevent people from getting tested for HIV, including lack of knowledge, competing priorities during medical visits, and stigma associated with the test on the part of both the patient and provider.
High blood levels of the serum C-peptide are linked to heart disease and death in people without diabetes, according to a large study published in CMAJ.
Genzyme, a Sanofi company, announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion for approval of LEMTRADA (alemtuzumab) for the treatment of adult patients with relapsing remitting multiple sclerosis with active disease defined by clinical or imaging features.
Implantable brain electrodes have been around for quite some time now, both for diagnosing and treating neuropsychiatric conditions like Parkinson's disease. However, one limitation of conventional probes is their size and rigidity, compared to the soft, gelatinous consistency of the brain.
› Verified 9 days ago